Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 76
Selected: 0
NCT IDTitle
NCT05853354Comparative Efficacy, Safety, PK, and Immunogenicity Study
NCT07236476Identify Effective Doses of LY01021 in Controlled Ovarian Hyperstimulation (COH) for Female Subjects Undergoing Assisted Reproductive Technology (ART)
NCT03785652Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LY03005 Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)
NCT06216054Safety, Tolerability and Pharmacokinetic of Multiple-ascending Doses of LPM3770164 in Healthy Subjects
NCT07516899Mass Balance Study of [14C] LPM3770164 in Healthy Participants
NCT06731868Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia
NCT02055274Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease
NCT06426485To Evaluate the Long-term Efficacy and Safety of Toludevenlafaxine Hydrochloride Sustained-release Tablets
NCT04088604Irinotecan Hydrochloride Liposome Injection (LY01610) For Advanced Solid Tumors
NCT02728947Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's Disease
NCT04563936Efficacy and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®
NCT04973722A Study to Evaluate LY06006 and Prolia in Healthy Adults
NCT03427853A Study to Evaluate the Denosumab in Healthy Adults
NCT07391566LPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer Patients With RAS Mutation
NCT05853341Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (13.3mg/24h)
NCT06793995Effect of Food and Age on the Pharmacokinetics of LY03017
NCT06247410Clinical Trial to Investigate Patch Adhesion of Rotigotine Containing Patches in Patients With Parkinson's Disease
NCT03733561A Study to Assess Pharmacokinetic Profiles of LY03003 and Neupro
NCT02988024Pilot BA Study of New LY03005 vs Pristiq
NCT05865925Safety, Tolerability, Pharmacokinetics (PK), and Primary Clinical Efficacy of LY01616 in Patients With Advanced Solid Tumors
NCT06980207A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017
NCT06240546First-in-Human Study of LPM6690176 in Patients With Advanced Solid Tumors.
NCT06128837Study of LY01610 in Patients With Recurrent Small Cell Lung Cancer
NCT04384666A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetic Profiles of Rotigotine After a Single Dose of LY03003 (28 mg) Versus After a Week of Daily NEUPRO® Transdermal Patch (4 mg Every 24 Hours) in Healthy Volunteers
NCT07371065To Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Food Effects of LY03021 in Healthy Chinese Subjects
NCT04198636A Study to Evaluate LY01011 and Xgeva® in Healthy Adults
NCT05060406A Study to Evaluate the Efficacy and Safety of LY06006 in Postmenopausal Women With Osteoporosis at High Risk for Fracture
NCT05238701A Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 in Healthy Subjects
NCT04627155A Study to Evaluate the Human Tolerance and Pharmacokinetics of LY03003
NCT04045678A Multiple Ascending Dose Study With LY03003 in Patients With Early-stage Parkinson's Disease
NCT03844438A Study Evaluating the Safety, Tolerability of LPM3480226 Tablets in Patients With Advanced Solid Tumors
NCT07396870A Phase 2 Study to Evaluate the Efficacy and Safety of LY03020 in Acutely Psychotic Participants With Schizophrenia
NCT02186769An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective Disorder
NCT04593511to Evaluate the Safety, Tolerability and Pharmacokinetics of Four Formulations of LY03009 in Healthy Volunteers
NCT04044547A Study of LY03003 in Patients With Early-stage Parkinson's Disease
NCT06496048Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLC
NCT04572698A Study to Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration(wAMD)
NCT04973735A Phase I Study of LY-CovMab Injection in Chinese Healthy Subjects
NCT06467409Phase II Clinical Trial to Evaluate the Efficacy and Safety of LPM3480392 Injection for Moderate to Severe Pain After Orthopedic Surgery
NCT04922593Relative Bioavailability of LY03010 Compared to Listed Drug
NCT04629404A Clinical Trial to Evaluate the Pharmacodynamics/Pharmacokinetics and Safety of LY03003 in Early PD Patients
NCT05856630Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mg
NCT06388551A Phase 1, SAD Study to Evaluate the Safety and Tolerability of LY03017
NCT06204120Phase II Clinical Trial to Evaluate the Efficacy and Safety of LPM3480392 Injection for Moderate to Severe Pain After Abdominal Surgery
NCT04630860A Study to Evaluate the Pharmacokinetics and Safety of LY03003 in Patients With Advanced-stage PD
NCT04638491Safety Tolerability Pharmacokinetic and Preliminary Efficacy in Chinese Advanced Solid Tumors Patients
NCT06098599Comparing the Pharmacokinetic Profile of LY01612 and CAELYX® in Chinese Subjects With Advanced Breast Cancer
NCT03733574A Study of LY03005 vs Pristiq
NCT07292233A Food Effect Study of LY03020 in Healthy Subjects
NCT03822065A Relative Bioavailability Food Effect Study of LY03005